MGX Metagenomi Inc. Company Current Liabilities

Metagenomi - graphic logo of issuer MGX

Metagenomi, Inc. (MGX) is a biotech startup in the R&D stage, characterized by a high cash burn rate without actual sales. The dynamics of current liabilities illustrate liability management, where the current status equals 0.01. Metagenomi, Inc. (MGX) is implementing advanced CRISPR tools, studying natural microbiomes for genome editing. However, the company lacks market influence, and revenue relies exclusively on partner research agreements.

MGX (metagenomi.co) Company Short-Term Debts history from 02/21/2024 to 10/31/2026

Analytical breakdowns and data insights for company Metagenomi Therapeutics (MGX)

- stock price and consensus target price:
Stock Price Metagenomi|MGX - Average Forecast Price
- market capitalization data:
Market Valuation Metagenomi, Inc.|MGX - Aggregate Business Value
- balance sheet net asset value indicators:
Book Value per Share Metagenomi|MGX - Book Capitalization|Market Capitalization to Book Value Ratio metagenomi.co|MGX - Company Balance Sheet Assets
- business debt structure and liquidity details:
Total Debt to Capital Metagenomi, Inc.|MGX - Long-Term Liabilities to Capital|Short-Term Debt to Equity Metagenomi, Inc.|MGX - Company Aggregate Debt|Debt to Book Capitalization Ratio Metagenomi, Inc.|MGX - Long-Term Debt|Company Short-Term Debt Metagenomi|Quick Ratio metagenomi.co
- net income and valuation multiples indicators:
MGX - Net Financial Result
Fundamental valuation:MGX - Metagenomi
Manufactured products of Metagenomi, Inc.

Decoupling fundamental value from speculative expectations requires an analysis of short-term loans due for repayment in the upcoming cycle. For Metagenomi, Inc. (MGX), whose successes in CRISPR therapy depend on R&D rather than GDP, the current debt obligation chart reflects the balance between capital inflows and servicing costs, confirming the company's financial stability in the absence of market cyclicality.

Main competitors

Tempus AI, Inc - Company Short-Term Debts|Short-Term Debt Qiagen NV|IONS (Ionis Pharma) - Company Current Liabilities|RGEN: Amount of Current Liabilities|RNA (Avidity Biosciences) - Company Short-Term Debts|Company Short-Term Debts crisprtx.com|Company Short-Term Debts WGS|Ultragenyx Pharmaceutical Inc. (RARE) - Short-Term Indebtedness|Company Short-Term Debts BEAM (Beam Therapeutics Corp)|Sarepta Corp (SRPT) - Short-Term Debt|TWST - Company Short-Term Debt|TXG (10xgenomics.com) - Company Short-Term Indebtedness|Intellia Therapeutics, Inc. (NTLA) - Company Short-Term Debt|Short-Term Debt Stoke Therapeutics Inc (STOK)|Company Short-Term Debt BioLife Corp|Company Current Liabilities Wave Pharma (WVE)|Company Short-Term Debts MAZE|Short-Term Debt Volume sionnatx.com|Prime Medicine - Company Current Liabilities|Company Short-Term Loans and Borrowings TSHA|uniQure Corp - Company Short-Term Debts|Short-Term Debt Volume MeiraGTx Corp MGTX|REGENXBIO Inc. (RGNX) - Company Short-Term Debt|Company Short-Term Indebtedness SLDB|OCGN (Ocugen) - Company Short-Term Debts|Company Current Liabilities Pacific Biosciences of California, Inc. (PACB)|Company Current Liabilities BNTC (Benitec)|Short-Term Debt Volume Design Corp|Company Short-Term Debt Rocket Pharmaceuticals RCKT|FDMT - Company Current Liabilities|Lexeo - Company Short-Term Debts|Short-Term Indebtedness Korro Bio, Inc. (KRRO)|EDIT (Editas) - Company Current Liabilities|Company Short-Term Indebtedness SLN|PRQR (ProQR) - Company Short-Term Debts|Company Short-Term Indebtedness CDXS (Codexis Bio)|Company Short-Term Debt Sangamo Therapeutics, Inc. (SGMO)|nautilus.bio - Company Short-Term Indebtedness|Company Short-Term Debts DTIL (Precision BioSciences)|Company Short-Term Debts Generation Bio Co GBIO|BOLD - Company Short-Term Debt|Exicure, Inc. (XCUR) - Company Current Liabilities|IMNN: Company Short-Term Debts|Short-Term Debt Phio Pharmaceuticals Corp. (PHIO)|Company Current Liabilities MBIO|RNAZ (TransCode) - Amount of Current Liabilities|Company Short-Term Debts BNGO|Company Short-Term Debts adnas.com (APDN)|Company Short-Term Debts BLUE (bluebird bio)|Short-Term Indebtedness ImmunoPrecise Antibodies Ltd|Omega - Company Short-Term Debts|Short-Term Debt Singular Genomics Corp|Regulus Therapeutics (RGLS) - Company Short-Term Debt|Company Short-Term Indebtedness SYRS|Company Short-Term Debt Telesis Bio|Short-Term Debt TRACON Pharmaceuticals Inc. TCON|Company Short-Term Debt Unity Bio (UBX)